ERBB2 and breast cancer: ErbB-2 class receptor binding was enriched in basal cells (q = 0.004), and numerous pathways critical to cell differentiation, survival and breast cancer were enriched in luminal including c-KIT, NOTCH, and GH receptor signaling (Fig. S1 B and Table S1).